PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportshyperlipidemias
MeSH D006949 - hyperlipidemias
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D050171:Dyslipidemias
8 Companies
11 Drugs
$
Success rate
D006949: 
Hyperlipidemias
1 Company
1 Drug
$
Success rate
D006937:Hypercholesterolemia
123 Companies
45 Drugs
$
Success rate
D006950:Familial combined hyperlipidemia
23 Companies
6 Drugs
$
Success rate
D006951:Hyperlipoproteinemias
102 Companies
21 Drugs
$
Success rate
D015228:Hypertriglyceridemia
116 Companies
37 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
79%
23/29
Phase 2
84%
27/32
Phase 3
38%
17/45
Approved: 0Overall Success rate: 25%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Ionis Pharmaceuticals
Olezarsen,
Doconexent,
Sodium chloride,
Pelacarsen,
VUPANORSEN,
Tqj230
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use